Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 26, 2022

SELL
$59.26 - $71.14 $8,414 - $10,101
-142 Reduced 30.87%
318 $21,000
Q1 2022

Apr 13, 2022

SELL
$55.72 - $67.12 $55,608 - $66,985
-998 Reduced 68.45%
460 $31,000
Q4 2021

Feb 14, 2022

SELL
$54.02 - $63.83 $6,266 - $7,404
-116 Reduced 7.37%
1,458 $85,000
Q3 2021

Nov 12, 2021

BUY
$55.56 - $60.79 $14,334 - $15,683
258 Added 19.6%
1,574 $95,000
Q2 2021

Aug 13, 2021

BUY
$48.42 - $60.18 $63,720 - $79,196
1,316 New
1,316 $79,000
Q1 2021

Apr 14, 2021

SELL
$47.16 - $54.44 $47,160 - $54,440
-1,000 Closed
0 $0
Q4 2020

Jan 14, 2021

BUY
$48.52 - $58.02 $97 - $116
2 Added 0.2%
1,000 $50,000
Q3 2017

Oct 27, 2017

SELL
$28.96 - $34.0 $3,475 - $4,080
-120 Reduced 10.73%
998 $34,000
Q2 2017

Aug 07, 2017

BUY
N/A
1,118
1,118 $0

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $240B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Loring Wolcott & Coolidge Fiduciary Advisors LLP Portfolio

Follow Loring Wolcott & Coolidge Fiduciary Advisors LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loring Wolcott & Coolidge Fiduciary Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Loring Wolcott & Coolidge Fiduciary Advisors LLP with notifications on news.